Table 4 Projected costs per 1000 patients
From: Cost-effectiveness of fenofibrate for preventing diabetic complications in Australia
Fenofibrate | No fenofibrate | Difference | |
|---|---|---|---|
Panel A: Costs of diabetes complications | |||
Amputations | AU $2.45 M | AU $4.83 M | AU -$2,37 M |
Blindness | AU $0.28 M | AU $0.34 M | AU -$0.06 M |
Coronary Heart failure | AU $2.81 M | AU $3.00 M | AU -$0.19 M |
Ischemic heart disease | AU $0.27 M | AU $0.59 M | AU -$0.32 M |
Myocardial infarction | AU $2.43 M | AU $3.81 M | AU -$1.38 M |
Renal failure | AU $1.60 M | AU $1.82 M | AU -$0.22 M |
Stroke | AU $2.50 M | AU $2.62 M | AU -$0.12 M |
CABG | AU $0.69 M | AU $ 0.66 M | AU $0.03 M |
Total complications costs | AU $13.05 M | AU $17.67 M | AU -$4.63 M |
Panel B | |||
Other costs | |||
Death costs | AU $17.96 M | AU $19.00 M | AU -$1.05 M |
Diabetes drug costs | AU $1.81 M | AU $1.71 M | AU $0.10 M |
Diabetes treatment costs | AU $40.85 M | AU $ 37.92 M | AU $2.93 M |
Fenofibrate costs | AU $3.06 M | AU $0 | AU $3.06 M |
Total costs | AU $63.67 M | AU $58.64 M | AU $5.03 M |